ALLMedicine™ Retinal Detachment Center
Research & Reviews 3,027 results
https://doi.org/10.1016/j.jcjo.2023.02.008
Canadian Journal of Ophthalmology. Journal Canadien D'oph... Santos GH, Fernandes RAB et. al.
Mar 26th, 2023 - To compare long-term outcomes of eyes undergoing Ahmed glaucoma drainage implants in the anterior chamber versus the pars plana. Retrospective study. Operated patients were divided into anterior-chamber or pars plana groups. Follow-up data include...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035235
BMC Ophthalmology; Noji S, Mizuno M et. al.
Mar 25th, 2023 - To determine the incidence and characteristics of the multiple subretinal particles (SRPs) present after pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD). The medical records of 224 eyes of 224 patients that underwent PPV fo...
https://doi.org/10.46883/2023.25920987
Oncology (Williston Park, N.Y.); Han J, Chen J et. al.
Mar 25th, 2023 - Mitogen-activated protein kinase (MEK) inhibitors, which integrate the important signaling chain of the RAS-RAF-MEK-ERK1/2 pathway, regulate cell functions such as division and proliferation for patients with solid tumors. However, various ocular ...
https://doi.org/10.1038/s41433-023-02495-y
Eye (London, England); Cristescu IE, Ivanova T et. al.
Mar 24th, 2023 - To investigate the anatomical and functional outcomes and specifically, the effect of 360-degree barrier-laser, in pars plana vitrectomy (PPV) for primary pseudophakic rhegmatogenous retinal detachment (PRD). We conducted a single-centre retrospec...
https://doi.org/10.1136/bcr-2022-253413
BMJ Case Reports; Linton E, Jasani K
Mar 24th, 2023 - A man in his 50s underwent vitrectomy surgery for a macular off retinal detachment which was complicated by intraoperative hypotony and suprachoroidal haemorrhage, resulting in the use of silicone oil tamponade. Postoperatively, several retained c...
Drugs 3 results see all →
Clinicaltrials.gov 286 results
https://clinicaltrials.gov/ct2/show/NCT01845571
Mar 15th, 2023 - Background: Rhegmatogenous retinal detachment is an ophthalmic emergency that, without surgical repair, often leads to blindness. The incidence is about 1/10000/year. The leading causes are myopia and aging which cause retinal tears often resultin...
https://clinicaltrials.gov/ct2/show/NCT05163093
Mar 7th, 2023 - 1.Inclusion criteria: (1)age: 45-79 years old, BCVA>0.3, 19mm
https://clinicaltrials.gov/ct2/show/NCT05523869
Mar 2nd, 2023 - Intravitreal topotecan has anti-inflammatory, anti-proliferative and anti-fibrotic activity that we hypothesize may exhibit high efficacy for the treatment of proliferative vitreoretinopathy (PVR) in patients with rhegmatogenous retinal detachment...
https://clinicaltrials.gov/ct2/show/NCT05739539
Feb 22nd, 2023 - Background and Rationale: Diabetic retinopathy (DR) is a leading cause of blindness among the working age group with increasing numbers of persons being affected worldwide. The microvascular complications of diabetes result in macular leakage or e...
https://clinicaltrials.gov/ct2/show/NCT05736757
Feb 21st, 2023 - Severe ocular rupture may be accompanied by suprachoroidal hemorrhage, or subretinal hemorrhage, or with suprachoroidal hemorrhage and subretinal hemorrhage. The suprachoroidal hemorrhage needs to be drained as soon as possible. The traditional tr...
News 150 results
https://www.medpagetoday.com/pediatrics/generalpediatrics/103097
Feb 14th, 2023 - Nightly use of 0.05% atropine eyedrops in kids led to a significantly lower incidence of myopia at 2 years, and a lower percentage with fast myopic shift, a randomized trial from Hong Kong showed. Among children ages 4 to 9 with no myopia but cons...
https://www.medscape.com/viewarticle/985174
Dec 7th, 2022 - There is no increased risk of tractional retinal detachment (TRD) associated with anti-VEGF (vascular endothelial growth factor) intravitreal injection only, compared with laser-only therapy, nor with 6 months or longer of loss to follow-up in pat...
https://www.onclive.com/view/investigators-seek-to-refocus-on-fgfr2-altered-cholangiocarcinoma
Oct 25th, 2022 - Treatment options for the management of patients with cholangiocarcinoma are rapidly expanding with multiple approved targeted therapies and immunotherapy. Investigators hope to add RLY-4008, the first highly selective FGFR2 inhibitor, to this gro...
https://www.onclive.com/view/encorafenib-binimetinib-delivers-prolonged-survival-in-braf-v600-mutant-melanoma
Oct 21st, 2022 - The combination of encorafenib (Braftovi) and binimetinib (Mektovi) led to sustained improvements in progression-free survival (PFS) and overall survival (OS), without new safety signals in patients with BRAF V600–mutant melanoma, according to 5-y...
https://www.medscape.com/viewarticle/982191
Oct 13th, 2022 - When is the last time you broke capsule during cataract surgery? Were you able place your intended lens in the intended location? How did your patient do? Did they need additional surgery? Did another complication arise because of the posterior ca...